Search Results | Diabetes Care | American Diabetes Association

1-20 of 35

Sort by

Sort Order Select

Journal Articles

Phenomapping-Derived Tool to Individualize the Effect of Canagliflozin on Cardiovascular Risk in Type 2 Diabetes

Evangelos K. Oikonomou, Marc A. Suchard, Darren K. McGuire, Rohan Khera

Diabetes Care 2022;45(4):965–974

DOI: https://doi.org/10.2337/dc21-1765

Published: 04 February 2022

View article

Journal Articles

Effect of Dapagliflozin on Hematocrit in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From DECLARE-TIMI 58

Ahmed A. Kolkailah, Stephen D. Wiviott, Itamar Raz, Sabina A. Murphy, Ofri Mosenzon, Deepak L. Bhatt, Lawrence A. Leiter, John P.H. Wilding, Ingrid Gause-Nilsson, Marc S. Sabatine, Darren K. McGuire

Diabetes Care 2022;45(2):e27–e29

DOI: https://doi.org/10.2337/dc21-1668

Published: 17 January 2022

View article

Journal Articles

Association of Baseline HbA_1c With Cardiovascular and Renal Outcomes: Analyses From DECLARE-TIMI 58

Avivit Cahn, Stephen D. Wiviott, Ofri Mosenzon, Erica L. Goodrich, Sabina A. Murphy, Ilan Yanuv, Aliza Rozenberg, Deepak L. Bhatt, Lawrence A. Leiter, Darren K. McGuire, John P.H. Wilding, Ingrid A.M. Gause-Nilsson, Anna Maria Langkilde, Marc S. Sabatine, Itamar Raz

Diabetes Care 2022;45(4):938–946

DOI: https://doi.org/10.2337/dc21-1744

Published: 11 January 2022

View article

Journal Articles

Cluster Analysis of Cardiovascular Phenotypes in Patients With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease: A Potential Approach to Precision Medicine

Abhinav Sharma, Yinggan Zheng, Justin A. Ezekowitz, Cynthia M. Westerhout, Jacob A. Udell, Shaun G. Goodman, Paul W. Armstrong, John B. Buse, Jennifer B. Green, Robert G. Josse, Keith D. Kaufman, Darren K. McGuire, Giuseppe Ambrosio, Lee-Ming Chuang, Renato D. Lopes, Eric D. Peterson, Rury R. Holman

Diabetes Care 2022;45(1):204–212

DOI: https://doi.org/10.2337/dc20-2806

Published: 29 October 2021

View article

Journal Articles

A Biomarker-Based Score for Risk of Hospitalization for Heart Failure in Patients With Diabetes

David D. Berg, Stephen D. Wiviott, Benjamin M. Scirica, Thomas A. Zelniker, Erica L. Goodrich, Petr Jarolim, Ofri Mosenzon, Avivit Cahn, Deepak L. Bhatt, Lawrence A. Leiter, Darren K. McGuire, John P.H. Wilding, Per Johanson, Anna Maria Langkilde, Itamar Raz, Eugene Braunwald, Marc S. Sabatine, David A. Morrow

Diabetes Care 2021;44(11):2573–2581

DOI: https://doi.org/10.2337/dc21-1170

Published: 17 September 2021

View article

Journal Articles

The Effect of Dapagliflozin on Albuminuria in DECLARE-TIMI 58

Diabetes Care 2021;44(8):1805–1815

DOI: https://doi.org/10.2337/dc21-0076

Published: 11 August 2021

View article

Journal Articles

Meta-analyses of Results From Randomized Outcome Trials Comparing Cardiovascular Effects of SGLT2is and GLP-1RAs in Asian Versus White Patients With and Without Type 2 Diabetes

Matthew M.Y. Lee, Nazim Ghouri, Darren K. McGuire, Martin K. Rutter, Naveed Sattar

Diabetes Care 2021;44(5):1236–1241

DOI: https://doi.org/10.2337/dc20-3007

Published: 11 March 2021

View article

Journal Articles

Cardiovascular, Renal, and Metabolic Outcomes of Dapagliflozin Versus Placebo in a Primary Cardiovascular Prevention Cohort: Analyses From DECLARE-TIMI 58

Avivit Cahn, Itamar Raz, Lawrence A. Leiter, Ofri Mosenzon, Sabina A. Murphy, Erica L. Goodrich, Ilan Yanuv, Aliza Rozenberg, Deepak L. Bhatt, Darren K. McGuire, John P.H. Wilding, Ingrid A.M. Gause-Nilsson, Anna Maria Langkilde, Marc S. Sabatine, Stephen D. Wiviott

Diabetes Care 2021;44(5):1159–1167

DOI: https://doi.org/10.2337/dc20-2492

Published: 02 March 2021

View article

Journal Articles

Diabetic Ketoacidosis and Related Events With Sotagliflozin Added to Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of the inTandem 1 and 2 Studies

Anne L. Peters, Darren K. McGuire, Thomas Danne, Jake A. Kushner, Helena W. Rodbard, Ketan Dhatariya, Sangeeta Sawhney, Phillip Banks, Wenjun Jiang, Michael J. Davies, Pablo Lapuerta

Diabetes Care 2020;43(11):2713–2720

DOI: https://doi.org/10.2337/dc20-0924

Published: 14 September 2020

View article

Journal Articles

Medicaid Expansion and Utilization of Antihyperglycemic Therapies

Andrew Sumarsono, Leo F. Buckley, Sara R. Machado, Rishi K. Wadhera, Haider J. Warraich, Rishi J. Desai, Brendan M. Everett, Darren K. McGuire, Gregg C. Fonarow, Javed Butler, Ambarish Pandey, Muthiah Vaduganathan

Diabetes Care 2020;43(11):2684–2690

DOI: https://doi.org/10.2337/dc20-0735

Published: 04 September 2020

View article

Journal Articles

Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial

Matthew J. Crowley, Darren K. McGuire, Anastasia-Stefania Alexopoulos, Thomas Jon Jensen, Søren Rasmussen, Hans A. Saevereid, Subodh Verma, John B. Buse

Diabetes Care 2020;43(9):e108–e110

DOI: https://doi.org/10.2337/dc20-0437

Published: 09 July 2020

View article

Journal Articles

Association of Long-term Change and Variability in Glycemia With Risk of Incident Heart Failure Among Patients With Type 2 Diabetes: A Secondary Analysis of the ACCORD Trial

Matthew W. Segar, Kershaw V. Patel, Muthiah Vaduganathan, Melissa C. Caughey, Javed Butler, Gregg C. Fonarow, Justin L. Grodin, Darren K. McGuire, Ambarish Pandey

Diabetes Care 2020;43(8):1920–1928

DOI: https://doi.org/10.2337/dc19-2541

Published: 15 June 2020

View article

Journal Articles

Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial

Vlado Perkovic, Robert Toto, Mark E. Cooper, Johannes F.E. Mann, Julio Rosenstock, Darren K. McGuire, Steven E. Kahn, Nikolaus Marx, John H. Alexander, Bernard Zinman, Egon Pfarr, Sven Schnaidt, Thomas Meinicke, Maximillian von Eynatten, Jyothis T. George, Odd Erik Johansen, Christoph Wanner

Diabetes Care 2020;43(8):1803–1812

DOI: https://doi.org/10.2337/dc20-0279

Published: 22 May 2020

View article

Journal Articles

Response to Comment on Segar et al. Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score. Diabetes Care 2019;42:2298–2306

Matthew W. Segar, Muthiah Vaduganathan, Darren K. McGuire, Mujeeb Basit, Ambarish Pandey

Diabetes Care 2020;43(2):e26–e27

DOI: https://doi.org/10.2337/dci19-0059

Published: 13 January 2020

View article

Journal Articles

Glycated Hemoglobin, Prediabetes, and the Links to Cardiovascular Disease: Data From UK Biobank

Claire Welsh, Paul Welsh, Carlos A. Celis-Morales, Patrick B. Mark, Daniel Mackay, Nazim Ghouri, Fredrick K. Ho, Lyn D. Ferguson, Rosemary Brown, James Lewsey, John G. Cleland, Stuart R. Gray, Donald M. Lyall, Jana J. Anderson, Pardeep S. Jhund, Jill P. Pell, Darren K. McGuire, Jason M.R. Gill, Naveed Sattar

Diabetes Care 2020;43(2):440–445

DOI: https://doi.org/10.2337/dc19-1683

Published: 18 December 2019

View article

Journal Articles

Efficacy and Safety of Dapagliflozin in the Elderly: Analysis From the DECLARE–TIMI 58 Study

Avivit Cahn, Ofri Mosenzon, Stephen D. Wiviott, Aliza Rozenberg, Ilan Yanuv, Erica L. Goodrich, Sabina A. Murphy, Deepak L. Bhatt, Lawrence A. Leiter, Darren K. McGuire, John P.H. Wilding, Ingrid A.M. Gause-Nilsson, Martin Fredriksson, Peter A. Johansson, Anna Maria Langkilde, Marc S. Sabatine, Itamar Raz

Diabetes Care 2020;43(2):468–475

DOI: https://doi.org/10.2337/dc19-1476

Published: 16 December 2019

View article

Includes: Supplementary data

Journal Articles

Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score

Matthew W. Segar, Muthiah Vaduganathan, Kershaw V. Patel, Darren K. McGuire, Javed Butler, Gregg C. Fonarow, Mujeeb Basit, Vaishnavi Kannan, Justin L. Grodin, Brendan Everett, Duwayne Willett, Jarett Berry, Ambarish Pandey

Diabetes Care 2019;42(12):2298–2306

DOI: https://doi.org/10.2337/dc19-0587

Published: 13 September 2019

View article

Includes: Supplementary data

Journal Articles

Aerobic Fitness and Adherence to Guideline-Recommended Minimum Physical Activity Among Ambulatory Patients With Type 2 Diabetes Mellitus

Jennifer L. Jarvie, Ambarish Pandey, Colby R. Ayers, Jonathan M. McGavock, Martin Sénéchal, Jarett D. Berry, Kershaw V. Patel, Darren K. McGuire

Diabetes Care 2019;42(7):1333–1339

DOI: https://doi.org/10.2337/dc18-2634

Published: 21 May 2019

View article

Includes: Supplementary data

Journal Articles

Improved Time in Range and Glycemic Variability With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of 24-Week Continuous Glucose Monitoring Data From the inTandem Program

Thomas Danne, Bertrand Cariou, John B. Buse, Satish K. Garg, Julio Rosenstock, Phillip Banks, Jake A. Kushner, Darren K. McGuire, Anne L. Peters, Sangeeta Sawhney, Paul Strumph

Diabetes Care 2019;42(5):919–930

DOI: https://doi.org/10.2337/dc18-2149

Published: 04 March 2019

View article

Includes: Supplementary data

Journal Articles

Fasiglifam-Induced Liver Injury in Patients With Type 2 Diabetes: Results of a Randomized Controlled Cardiovascular Outcomes Safety Trial

Venu Menon, A. Michael Lincoff, Stephen J. Nicholls, Susan Jasper, Kathy Wolski, Darren K. McGuire, Cyrus R. Mehta, Julio Rosenstock, Claudia Lopez, John Marcinak, Charlie Cao, Steven E. Nissen

Diabetes Care 2018;41(12):2603–2609

DOI: https://doi.org/10.2337/dc18-0755

Published: 12 November 2018

View article

Includes: Supplementary data

NARROW

Phenomapping-Derived Tool to Individualize the Effect of Canagliflozin on Cardiovascular Risk in Type 2 Diabetes

Effect of Dapagliflozin on Hematocrit in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From DECLARE-TIMI 58

Association of Baseline HbA_1c With Cardiovascular and Renal Outcomes: Analyses From DECLARE-TIMI 58

Cluster Analysis of Cardiovascular Phenotypes in Patients With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease: A Potential Approach to Precision Medicine

A Biomarker-Based Score for Risk of Hospitalization for Heart Failure in Patients With Diabetes

The Effect of Dapagliflozin on Albuminuria in DECLARE-TIMI 58

Meta-analyses of Results From Randomized Outcome Trials Comparing Cardiovascular Effects of SGLT2is and GLP-1RAs in Asian Versus White Patients With and Without Type 2 Diabetes

Cardiovascular, Renal, and Metabolic Outcomes of Dapagliflozin Versus Placebo in a Primary Cardiovascular Prevention Cohort: Analyses From DECLARE-TIMI 58

Diabetic Ketoacidosis and Related Events With Sotagliflozin Added to Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of the inTandem 1 and 2 Studies

Medicaid Expansion and Utilization of Antihyperglycemic Therapies

Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial

Association of Long-term Change and Variability in Glycemia With Risk of Incident Heart Failure Among Patients With Type 2 Diabetes: A Secondary Analysis of the ACCORD Trial

Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial

Response to Comment on Segar et al. Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score. Diabetes Care 2019;42:2298–2306

Glycated Hemoglobin, Prediabetes, and the Links to Cardiovascular Disease: Data From UK Biobank

Efficacy and Safety of Dapagliflozin in the Elderly: Analysis From the DECLARE–TIMI 58 Study

Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score

Aerobic Fitness and Adherence to Guideline-Recommended Minimum Physical Activity Among Ambulatory Patients With Type 2 Diabetes Mellitus

Improved Time in Range and Glycemic Variability With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of 24-Week Continuous Glucose Monitoring Data From the inTandem Program

Fasiglifam-Induced Liver Injury in Patients With Type 2 Diabetes: Results of a Randomized Controlled Cardiovascular Outcomes Safety Trial

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only